Bicara Therapeutics Common Stock Overview
Bicara Therapeutics Common Stock Discounted Cash Flow
DCF Analysis for BCAX.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.74
Current Fair Value
$1.74
↓ 92.0% Downside
Overvalued by 92.0% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison